Linked Data API

Show Search Form

Search Results

170098
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Public Relations more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much (a) NHS England, (b) Public Health England, (c) Monitor and (d) the Care Quality Commission spent on public relations and communications staff in (i) each year since 2010 and (ii) 2014 to date. more like this
tabling member constituency Denton and Reddish more like this
tabling member printed
Andrew Gwynne more like this
uin 218532 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>Below are details of how much each of the four bodies has spent on public relations and communications staff since 2010 or from when the data are available.</p><p> </p><p> </p><p> </p><p>To ensure consistency all organisations have provided data according to the following criteria for public relations (PR) and communications staff:</p><p> </p><p> </p><p> </p><p>- Press and PR</p><p> </p><p>- Stakeholder relations</p><p> </p><p>- Campaigns (not behaviour change policy)</p><p> </p><p>- Digital Comms (not IT/digital service teams)</p><p> </p><p>- Internal Comms</p><p> </p><p> </p><p> </p><p>(a) NHS England</p><p> </p><p> </p><p> </p><p>On 1 October 2012, the functions of the Board Authority transferred to the NHS Commissioning Board (also known as NHS England), which was formally established as an executive non departmental public body. NHS England took on all of its statutory functions in April 2013. Figures have been given from 1 October 2012.</p><p> </p><p> </p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>NHS England</p></td><td><p>2012/13</p><p>(October – April)</p></td><td><p>2013/14</p><p>(April – March)</p></td><td><p>2014/15</p><p>(April – November)</p></td></tr><tr><td><p>National Communications</p></td><td><p>£253,963</p></td><td><p>£584,419</p></td><td><p>£1,040,240</p></td></tr><tr><td><p>Communications in local areas</p></td><td> </td><td><p>£3,558,677</p></td><td><p>£2,595,881</p></td></tr><tr><td><p>NHS Improving Quality (NHS IQ)</p></td><td> </td><td><p>£325,265</p></td><td><p>£461,232</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>(b) Public Health England (PHE)</p><p> </p><p> </p><p> </p><p>PHE was formed on 1 April 2013 - figures from predecessor bodies are not provided.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Public Health England</p></td><td><p>2013/14</p></td><td><p>2014/15</p><p>(to November)</p></td></tr><tr><td><p>PR and Communications staff expenditure</p></td><td><p>£2,888,000</p></td><td><p>£2,323,000</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>(c) Monitor</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Monitor</p></td><td><p>2010<del class="ministerial">/11</del></p><p>(April – December)</p></td><td><p>2011<del class="ministerial">/12</del></p></td><td><p>2012<del class="ministerial">/13</del></p></td><td><p>2013<del class="ministerial">/14</del></p></td><td><p>2014<del class="ministerial">/15</del></p><p>(to November)</p></td></tr><tr><td><p>PR and Communications staff expenditure</p></td><td><p>£398,973.20</p><p> </p></td><td><p>£526,784.85</p></td><td><p>£486,320.81</p></td><td><p>£1,066,790.92</p></td><td><p>£1,223,775.43</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>(d) Care Quality Commission (CQC)</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>CQC</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td><td><p>2014/15</p><p>(to November)</p></td></tr><tr><td><p>PR and Communications staff expenditure</p></td><td><p>£568,951</p></td><td><p>£736,238</p></td><td><p>£1,188,519</p></td><td><p>£1,039,669</p></td><td><p>£780,195</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
less than 2015-01-05T15:28:13.64Zmore like thismore than 2015-01-05T15:28:13.64Z
question first ministerially corrected
less than 2015-01-07T11:11:25.253Zmore like thismore than 2015-01-07T11:11:25.253Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
previous answer version
36869
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
1506
label Biography information for Andrew Gwynne more like this
170099
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Health: Screening more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many GP-requested (a) chest x-ray, (b) non-obstetric ultrasound, (c) flexi-sigmoidoscopies, (d) colonoscopies and (e) brain MRIs took place in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 218536 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-17more like thismore than 2014-12-17
answer text <p>The information requested is not available in the format requested.</p><p> </p><p> </p><p> </p><p>A breakdown of the number of diagnostic tests requested by general practitioners (GPs) is not collected separately. Information is collected on the number of diagnostic tests requested by all referrers, including GPs, and is shown in the table below.</p><p> </p><p> </p><p> </p><p>Number of non-obstetric ultrasounds, flexible sigmoidoscopy, colonoscopy and MRI tests, 2009-10 to 2013-14</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Number of Non-obstetric ultrasounds tests</p></td><td><p>Number of Flexible sigmoidoscopy</p><p>tests</p></td><td><p>Number of</p><p>Colonoscopy</p><p>tests</p></td><td><p>Number of MRI</p><p>tests</p></td></tr><tr><td><p>2009-10</p></td><td><p>5,073,625</p></td><td><p>197,342</p></td><td><p>315,657</p></td><td><p>1,895,842</p></td></tr><tr><td><p>2010-11</p></td><td><p>5,353,578</p></td><td><p>200,462</p></td><td><p>324,429</p></td><td><p>2,035,440</p></td></tr><tr><td><p>2011-12</p></td><td><p>5,592,035</p></td><td><p>217,767</p></td><td><p>360,443</p></td><td><p>2,192,511</p></td></tr><tr><td><p>2012-13</p></td><td><p>5,918,780</p></td><td><p>232,674</p></td><td><p>399,637</p></td><td><p>2,407,441</p></td></tr><tr><td><p>2013-14</p></td><td><p>6,314,999</p></td><td><p>228,756</p></td><td><p>401,278</p></td><td><p>2,667,286</p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source: </em>Monthly diagnostic waiting times and activity, NHS England</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2014-12-17T16:59:50.527Zmore like thismore than 2014-12-17T16:59:50.527Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4026
label Biography information for Liz Kendall more like this
170100
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Disability Aids more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps he is taking to encourage health authorities to reclaim and re-use disability adaptations and equipment that are no longer required by clients. more like this
tabling member constituency South Shields more like this
tabling member printed
Mrs Emma Lewell-Buck more like this
uin 218541 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>National Health Service trusts have a responsibility for making the best use of all resources and items where they are safely and legally reusable and returnable. Policy on the return of equipment is a matter for each trust and should be clear in each trust’s Sustainable Development Management Plan.</p><p> </p> more like this
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
question first answered
less than 2015-01-05T15:23:20.237Zmore like thismore than 2015-01-05T15:23:20.237Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4277
label Biography information for Mrs Emma Lewell-Buck more like this
170101
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Breast Cancer: Tamoxifen more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what discussions his Department has had with the National Institute for Health and Care Excellence about a technology appraisal for tamoxifen in the chemoprevention indication. more like this
tabling member constituency Belfast East more like this
tabling member printed
Naomi Long more like this
uin 218545 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-17more like thismore than 2014-12-17
answer text <p>In June 2013 the National Institute for Health and Care Excellence (NICE) issued an updated clinical guideline on familial breast cancer which includes recommendations on the use of tamoxifen and raloxifene outside their licensed indications for the prevention of cancer in specific groups of women at high and moderate risk of breast cancer.</p><p> </p><p> </p><p> </p><p>NICE’s clinical guidelines represent best practice and we expect commissioners to take their recommendations into account when designing services and making commissioning decisions for their healthcare population.</p><p> </p><p><strong> </strong></p><p> </p><p>Our assessment is that, as NICE has already provided guidance on the use of tamoxifen and raloxifene, there would be little value in NICE separately appraising these drugs for the prevention of breast cancer and we have had no discussions with NICE on this issue.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 218463 more like this
question first answered
less than 2014-12-17T17:20:27.857Zmore like thismore than 2014-12-17T17:20:27.857Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3920
label Biography information for Naomi Long more like this
170102
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many breast cancer clinicians he spoke to directly when developing his policy on the Off-patent Drugs Bill. more like this
tabling member constituency Belfast East more like this
tabling member printed
Naomi Long more like this
uin 218546 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-17more like thismore than 2014-12-17
answer text <p>In developing our response to the Bill, we have taken advice from a number of cancer clinicians including breast cancer specialists and from officials at the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency, and taken account of views expressed by other stakeholder organisations.</p><p> </p><p> </p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 218462 more like this
question first answered
less than 2014-12-17T17:11:40.23Zmore like thismore than 2014-12-17T17:11:40.23Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3920
label Biography information for Naomi Long more like this
170103
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, which Off-patent drugs will be considered under the Early Access Scheme. more like this
tabling member constituency Belfast East more like this
tabling member printed
Naomi Long more like this
uin 218547 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>Off-patent drugs are those whose patent period has expired and consequently manufacturers may make available generic or non-branded versions of the products.</p><p> </p><p> </p><p> </p><p>An “off-label” medicine is any medicine prescribed outside the terms of its licence (as set out in the prescribing information in the Summary of product Characteristics). Medicines legislation permits prescribers to prescribe a product outside the terms of its licence where they judge it to be in the best interests of the patient to address a medical need. For example to prescribe for a different use or to different category of patients but in doing so the prescriber takes personal responsibility for the treatment, inform the patient(s) of the licensing status of the product and obtain consent from the patient for its use.</p><p> </p><p> </p><p> </p><p>The Early Access to Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need. Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will provide a scientific opinion on the benefit/risk balance of the medicine, based on the data available at the time of the EAMS submission. The scheme is voluntary and as such the MHRA is dependent on companies submitting potential products that may fulfil the EAMS criteria.</p><p> </p><p> </p><p> </p><p>In the government response to the public consultation, it was confirmed that off-label supply of existing medicines would be eligible for the scheme, but only if they meet the EAMS criteria. Thus companies can submit an application to the EAMS for a new indication for an already marketed drug (which may be off patent).</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-01-05T15:18:26.163Zmore like thismore than 2015-01-05T15:18:26.163Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3920
label Biography information for Naomi Long more like this
170105
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will make an assessment of the potential merits of allowing two Patient Access Schemes for one treatment; and if he will make a statement. more like this
tabling member constituency Southend West more like this
tabling member printed
Mr David Amess more like this
uin 218554 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-17more like thismore than 2014-12-17
answer text <p>Whilst we recognise there are benefits to be derived from Patient Access Schemes (PAS), both the 2009 and 2014 Pharmaceutical Price Regulation Schemes (PPRS), negotiated with the United Kingdom pharmaceutical industry, set out that PAS should be the exception rather than the rule. It is important that PAS are operationally manageable for the National Health Service, and any burden for the NHS should be proportionate to the benefits of the PAS for the NHS and patients.</p><p> </p><p> </p><p> </p><p>The 2009 and 2014 schemes set out the Department’s and the Association of the British Pharmaceutical Industry’s commitment to ensure that the cumulative burden on all parties involved in the operation of PAS is manageable. The PPRS recognises that it is reasonable for the Department to take this issue into account when considering the viability of individual PAS proposals.</p><p> </p><p> </p><p> </p><p>The 2014 PPRS states that the Department is unlikely to agree more than one PAS for a single product because of the complexity this would introduce for the NHS.</p><p> </p><p><strong> </strong></p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 218458 more like this
question first answered
less than 2014-12-17T17:16:52.86Zmore like thismore than 2014-12-17T17:16:52.86Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
44
label Biography information for Sir David Amess more like this
170106
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading NHS 111 more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of the effect of the 111 NHS telephone service on attendance at hospital accident and emergency departments. more like this
tabling member constituency Mid Worcestershire more like this
tabling member printed
Sir Peter Luff more like this
uin 218555 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>NHS 111 providers across England conduct patient follow up surveys on the NHS 111 service. The results for the year ending September 2014 showed that 30% of patients said they would have used accident and emergency services if they had not contacted NHS 111. This compares with a national rate of 8% of NHS 111 calls answered that directed patients to accident and emergency services.</p><p> </p><p> </p><p> </p><p>These results indicate that in a high proportion of cases NHS 111 has been effective in offering patients a service choice which, if followed, would direct more cases to non-emergency services than if NHS 111 was not available.</p><p> </p><p> </p><p> </p><p>There is a very active programme of work involving NHS England, working with local commissioners and NHS 111 providers, to improve referrals to alternative services. This programme is starting to see more patients who call NHS 111 directed to services for a lower acuity.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-01-05T17:09:52.807Zmore like thismore than 2015-01-05T17:09:52.807Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
268
label Biography information for Sir Peter Luff more like this
170107
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading Maternity Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, on how many days maternity units at each (a) NHS Trust and (b) NHS Foundation were put on divert in the last 12 months. more like this
tabling member constituency City of Durham more like this
tabling member printed
Roberta Blackman-Woods more like this
uin 218539 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-17more like thismore than 2014-12-17
answer text <p>This information is not collected centrally.</p><p> </p> more like this
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
grouped question UIN
218459 more like this
218460 more like this
question first answered
less than 2014-12-17T17:40:06.047Zmore like thismore than 2014-12-17T17:40:06.047Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
1501
label Biography information for Dr Roberta Blackman-Woods more like this
170128
registered interest false more like this
date less than 2014-12-12more like thismore than 2014-12-12
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health remove filter
answering dept sort name Health more like this
hansard heading General Dental Council more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what representations his Department has received on the Professional Standards Authority's 2014 report on the General Dental Council. more like this
tabling member constituency Copeland more like this
tabling member printed
Mr Jamie Reed more like this
uin 218587 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-17more like thismore than 2014-12-17
answer text <p>As at 15 December 2014 the Department has received one representation about the Professional Standards Authority's 2014 report on the General Dental Council (GDC), which was from the British Dental Association regarding the competence of the GDC. My noble Friend, the Parliamentary Under-Secretary of State for Quality (Earl Howe), provided a response on 28 July 2014 and I provided a response on 1 August 2014.</p><p> </p><p><strong> </strong></p><p> </p> more like this
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
less than 2014-12-17T16:51:06.483Zmore like thismore than 2014-12-17T16:51:06.483Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
1503
label Biography information for Mr Jamie Reed more like this